Evidence map›Paper›PMID 42891133›Full record

ArticleJHLT open2026

Out-of-bed mobility during venovenous ECMO among patients listed for lung transplantation: A descriptive single-center cohort study.

F Burke, A Nyquist, Z Kattih, O A Shlobin, S Aryal, V Khangoora, S Kilaru, A Singhal, J M Chowdhury, C A Thomas and 3 more

Abstract read
In one paragraph

Article in JHLT open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

F BurkeInova Fairfax Hospital, Falls Church, VA.
A NyquistAdvanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, VA.
Z KattihAdvanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, VA.
O A ShlobinAdvanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, VA.
S AryalAdvanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, VA.
V KhangooraAdvanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, VA.
S KilaruAdvanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, VA.
A SinghalAdvanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, VA.
J M ChowdhuryAdvanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, VA.
C A ThomasAdvanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, VA.
D TangCardiothoracic Surgery, Inova Fairfax Hospital, Falls Church, VA.
S D NathanAdvanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, VA.
C S KingAdvanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, VA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Out-of-bed (OOB) mobility is often expected of patients bridged to lung transplantation (LTx) on venovenous (VV) extracorporeal membrane oxygenation (ECMO), but the course of listed patients who never achieve it is poorly described. We describe mobility and outcomes in these patients at one center. Methods: We retrospectively reviewed patients bridged to LTx with VV ECMO between January 2019 and June 2025 at one center; the analytic cohort was restricted to listed patients. OOB mobility was a maximum nurse-rated score ≥5 on a 7-point institutional scale. Outcomes included 1-year post-transplant survival, survival to LTx, hospital survival, discharge disposition, length of stay, ventilation duration, and tracheostomy, reported descriptively with exact 95% confidence intervals (CIs). Results: Of 23 listed patients, 20 (87.0%) achieved OOB mobility and 3 (13.0%) did not. All 3 who never mobilized underwent transplantation and survived to discharge and to 1 year (3/3; 95% CI, 29.2-100). Among the 20 who mobilized, 19 survived to LTx (95.0%; 95% CI, 75.1-99.9), 18 to discharge (90.0%; 95% CI, 68.3-98.8), and 17 of the 19 transplanted to 1 year (89.5%; 95% CI, 66.9-98.7). Intervals were wide and overlapping. Four further patients were assessed but not listed; none achieved OOB mobility, and all died without transplantation. Conclusion: Three listed patients who never achieved OOB mobility were transplanted and survived to 1 year. Because the cohort is conditioned on prior acceptance for listing and the comparison group contains three patients, these observations are descriptive and cannot determine how OOB mobility should weigh in candidacy decisions.

Indexed as

bridge to transplantationextracorporeal membrane oxygenationlung transplantationout-of-bed mobilityphysical functionrehabilitation

Identifiers

PMID42891133
PMCPMC13673361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.